M42 to host eminent speakers during the inaugural Abu Dhabi Global Healthcare Week

UAE's health-tech powerhouse M42 announced the lineup of top global health experts to convene on the M42 Main Stage at the inaugural Abu Dhabi Global Healthcare Week 2024 (ADGHW).

Hosted by the Department of Health - Abu Dhabi (DoH), under the patronage of His Highness Sheikh Khaled bin Mohamed bin Zayed Al Nahyan, Crown Prince of Abu Dhabi and Chairman of Abu Dhabi Executive Council - ADGHW will take place from 13 to 15 May at the Abu Dhabi National Exhibition Centre (ADNEC) under the theme: "Accelerating the Future of Global Healthcare."

M42 Main Stage

As the Foundation Partner, M42 will host renowned international speakers, including:

• Dr. David Rhew, Global Chief Medical Officer at Microsoft
• Dr. David Sinclair, Professor of Epigenetics and Longevity at Harvard
• Octavius Black CBE, Co-Founder and CEO of MindGym
• Dr Richard Marshall CBE, MD, PhD, physician and scientist
• Louise Newson, GP and Menopause Specialist
• Andrew J Scott, a Professor of Economics at London Business School and a consulting scholar at Stanford University's Center on Longevity
• Andrea B. Maier, MD, FRACP, a leading gerontologist
• Jim Mellon, co-founder and Deputy Chairman of Juvenescence

M42's Main Stage promises a dynamic and immersive experience featuring a robust daily program designed to captivate and inspire. From sessions on preventive health strategies aimed at extending healthy lifespans to insightful dialogues on the pivotal role of nutrition in maintaining wellness, every session has been meticulously curated to offer invaluable insights. Moreover, attendees will have the opportunity to delve into global best practices and witness firsthand M42's groundbreaking health-tech innovations that spotlight personalized health, precision care and the integration of data and artificial intelligence in healthcare.

The M42 Main Stage is positioned in the Atrium from 13 to 15 May 2024 at ADNEC.

On the record

"The Department of Health - Abu Dhabi (DoH) and Abu Dhabi Global Healthcare Week are delighted to build on the ongoing collaboration with leading organizations such as M42. As the Foundation Partner, we look forward to leveraging their vast expertise in genomics and artificial intelligence (AI) with the aim of accelerating the future of healthcare on the global stage. Across the three-day event, the "always on" platform will convene leading researchers, policymakers, healthcare specialists, investors and entrepreneurs," said H.E. Dr. Noura Al Ghaithi, Undersecretary of the Department of Health - Abu Dhabi (DoH). "Together, we will chart a course for a healthier future, prioritizing good health and quality care across the globe and solving tomorrow's healthcare challenges, today."

"M42 is committed to shaping a sustainable and inclusive health ecosystem enabled by technology. Our focus is on health, not just healthcare. With the support and visionary leadership of the UAE, M42, as the Foundation Partner at Abu Dhabi Global Healthcare Week 2024, is leveraging preventive, precise, and personalized health-tech, including genomics and AI, to transform traditional healthcare," added Hasan Jasem Al Nowais, Managing Director and Group CEO of M42. "Our goal is to positively impact and disrupt the global health landscape, putting health back into your own hands. This reinforces our commitment to fostering responsible innovation, driving sustainable growth and creating a future where health is accessible and prioritized for every individual."

The context

ADGHW will explore the paradigm shift from reactive to proactive care. It will serve as a catalyst for the exchange of ideas and insights, gathering pioneering minds and a powerful network of 5,000 attendees, 1,000 delegates, 200 speakers and 100 exhibitors.

ADGHW is a major government initiative from the Department of Health - Abu Dhabi which aims to accelerate collaboration, innovation, and investment, and bring together researchers, policymakers, healthcare specialists, investors, and entrepreneurs across the global healthcare and life-science ecosystem.